Abstract: An anti-PD-1 antibody or an antigen-binding fragment thereof, nucleic acid molecules encoding same, and methods for preparing same. The anti-PD-1 antibody or the antigen-binding fragment thereof has high specificity and high affinity to PD-1, and can effectively block the binding of PD-1/PD-L1 and PD-1/PD-L2 so as to activate the immune system, thereby achieving the effect of inhibiting tumor growth. Therefore, a pharmaceutical composition containing the antibody or the antigen-binding fragment thereof and a use of the pharmaceutical composition in preparation of drugs are further comprised. The drugs are used for preventing and/or treating tumors, infections, or autoimmune diseases.

Abstract: The disclosure relates to a bioactive molecule conjugate, preparation methods and use thereof, particularly relates to a novel bioactive molecule conjugate obtained by improving coupling of the drug and the targeting moiety in an ADC or SMDC, as well as its preparation method and use in the manufacture of a medicament for the treatment of a disease associated with an abnormal cell activity.

Abstract: The disclosure relates to a bioactive molecule conjugate, preparation methods and use thereof, particularly relates to a novel bioactive molecule conjugate obtained by improving coupling of the drug and the targeting moiety in an ADC or SMDC, as well as its preparation method and use in the manufacture of a medicament for the treatment of a disease associated with an abnormal cell activity.

Abstract: The disclosure relates to a bioactive molecule conjugate, preparation methods and use thereof, particularly relates to a novel bioactive molecule conjugate obtained by improving coupling of the drug and the targeting moiety in an ADC or SMDC, as well as its preparation method and use in the manufacture of a medicament for the treatment of a disease associated with an abnormal cell activity.

Abstract: The disclosure relates to a bioactive molecule conjugate, preparation methods and use thereof, particularly relates to a novel bioactive molecule conjugate obtained by improving coupling of the drug and the targeting moiety in an ADC or SMDC, as well as its preparation method and use in the manufacture of a medicament for the treatment of a disease associated with an abnormal cell activity.

Abstract: Imaging devices and processing techniques based on imaging information along the depth direction in an optical coherent tomography (OCT) image are disclosed to enhance observed morphological features. The methods and systems obtain different OCT images of the target object under different reference path lengths, process the different OCT images to obtain a derivative with respect to the signal path length of image information of the different images, and processing the derivative to extract improved image information of the target object. The derivatives may be in a form related to a gradient value of the normalized OCT image intensity, or an attenuation coefficient.

Abstract: Imaging devices and processing techniques based on imaging information along the depth direction in an optical coherent tomography (OCT) image are disclosed to enhance observed morphological features. The methods and systems obtain different OCT images of the target object under different reference path lengths, process the different OCT images to obtain a derivative with respect to the signal path length of image information of the different images, and processing the derivative to extract improved image information of the target object. The derivatives may be in a form related to a gradient value of the normalized OCT image intensity, or an attenuation coefficient.